In this Perspective, I discuss the limitations of a soft primary endpoint that is used in some of the recent randomized phase II/III clinical trials. Unfortunately, many clinicians and investigators do not interpret the data critically to recognize the limitations of such findings. I advise against over-interpreting the effects of an intervention on a soft primary endpoint.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1007/s11010-024-05098-7 | DOI Listing |
Publication Analysis
Top Keywords
clinical trials
8
soft primary
8
primary endpoint
8
"the unbearable
4
unbearable lightness"
4
lightness" primary
4
primary point
4
point clinical
4
trials perspective
4
perspective discuss
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!